In the same way, Ye et al. demonstrated that the use of a combined treatment with fucoxanthin and TRAIL could be a useful strategy against TRAIL-resistant cervical cancer by acting on the upregulation of the PI3K/Akt pathway [83,139]. This evidence concerns the gene AKT1 and cervical carcinoma.